Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Gabather AB (publ)

GABA.ST

HealthcareSTOSE

SEK 0.0418

-SEK 0.0066 (-13.64%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

GABA.ST

1Y-0.0066 (-13.64%)

Candles, volume, SMA 20, and SMA 50

O 0.0462H 0.0462L 0.039C 0.0418Date Jun 10

GABA.ST

SMA 20 SMA 50 Vol 15.49M

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Gabather AB (publ) is dedicated to creating innovative pharmaceutical solutions for a range of central nervous system disorders. The company's focus includes developing medications for conditions such as psychotic illnesses, mood and anxiety disorders, pain relief, and cognitive function enhancement, notably those related to Alzheimer's disease. Founded in 2014, its operations are headquartered in Södertälje, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$9.87M

Volume?15.49M

Avg Volume?7.37M

52w RangeSEK 0.023 - SEK 0.13

Beta?-0.76

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide